Bristol-Myers Squibb Company Announces Workforce Reductions
SOURCENews reportView the filing ↗
What we know
Location: New Jersey, USA.
Department affected: cell therapy vector production.
Based on news reporting.
Summary
Bristol-Myers Squibb Company has announced a reduction in its workforce, affecting approximately 300 employees as part of a restructuring effort. This decision comes amid ongoing challenges in the pharmaceutical industry, with the company aiming to streamline operations and improve efficiency. The layoffs are expected to take effect immediately, impacting various departments within the organization. The company has indicated that these changes are necessary to better align with its strategic goals and respond to market demands. This move reflects a broader trend in the industry as companies adjust to economic pressures and changing market conditions.
Bristol-Myers Squibb Company cut 300 jobs in NJ affecting its cell therapy vector production team as of February 23, 2026.
That is roughly 0.9% of the 34,100 people Bristol-Myers Squibb Company employs.
LayoffTalk has tracked 30 layoff events at Bristol-Myers Squibb Company since November 2022, including 4,575 jobs documented in official WARN filings, with 17 additional events known from news reporting.
Comments (0)
Anonymous by default. Be kind — people reading this may be going through it right now.
No comments yet. Be the first to share your thoughts.
Affected by this?
Share your story anonymously — it helps others reading this feel less alone.
Share your story →More layoffs at Bristol-Myers Squibb Company
Recent tracked events at this company.
Recent layoffs in NJ
Other companies with tracked events in the same state.